Eli Lilly's fourth-quarter revenue was USD 19.29 billion, a year-on-year increase of 43%. The expected full-year revenue is between USD 80 billion and USD 83 billion, with market expectations at USD 77.71 billion

Wallstreetcn
2026.02.04 11:47
portai
I'm PortAI, I can summarize articles.

Eli Lilly's fourth-quarter revenue was USD 19.29 billion, a year-on-year increase of 43%. The full-year revenue is expected to be between USD 80 billion and USD 83 billion, with market expectations at USD 77.71 billion

Eli Lilly's fourth-quarter revenue was USD 19.29 billion, a year-on-year increase of 43%. The expected full-year revenue is between USD 80 billion and USD 83 billion, while the market expectation is USD 77.71 billion.

Risk Warning and Disclaimer

The market has risks, and investment requires caution. This article does not constitute personal investment advice and does not take into account the individual user's specific investment goals, financial situation, or needs. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Investment based on this is at one's own risk

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.